ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Pancreatic Cancer
2000 • 7,332 citations
Cancer Statistics, 2006
2006 • 5,351 citations
Pancreatic cancer
2004 • 1,663 citations
ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions.
1995 • 507 citations
Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
2001 • 329 citations
Metalloproteinases and their inhibitors in tumor angiogenesis
2005 • 300 citations
Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis
2005 • 207 citations
Catalytic Activity of ADAM8, ADAM15, and MDC-L (ADAM28) on Synthetic Peptide Substrates and in Ectodomain Cleavage of CD23
2003 • 176 citations
The Metalloprotease Disintegrin ADAM8
2002 • 159 citations
ADAM8 as a Novel Serological and Histochemical Marker for Lung Cancer
2004 • 145 citations
The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs
2002 • 144 citations
Metalloproteinase Disintegrins ADAM8 and ADAM19 Are Highly Regulated in Human Primary Brain Tumors and their Expression Levels and Activities Are Associated with Invasiveness
2006 • 138 citations
ADAM family proteins in the immune system
1999 • 137 citations
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
2004 • 133 citations
Tumor Necrosis Factor α Induces a Metalloprotease-Disintegrin, ADAM8 (CD 156): Implications for Neuron–Glia Interactions during Neurodegeneration
2000 • 132 citations
Pancreatic Cancer
2006 • 127 citations
Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage
1990 • 124 citations
Ectodomain Shedding of the Neural Recognition Molecule CHL1 by the Metalloprotease-disintegrin ADAM8 Promotes Neurite Outgrowth and Suppresses Neuronal Cell Death
2004 • 122 citations
ADAMs, cell migration and cancer
2006 • 118 citations
ADAM8: A Novel Osteoclast Stimulating Factor
2001 • 106 citations
CD156 (Human ADAM8): Expression, Primary Amino Acid Sequence, and Gene Location
1997 • 104 citations
Expression and Regulation of a Disintegrin and Metalloproteinase (ADAM) 8 in Experimental Asthma
2004 • 103 citations
Oxidative Stress Induces ADAM9 Protein Expression in Human Prostate Cancer Cells
2006 • 99 citations
Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8
2006 • 82 citations
Identification of Genes Differentially Induced by Hypoxia in Pancreatic Cancer Cells
2001 • 81 citations
Aberrant Expression of a Disintegrin and Metalloproteinase 17/Tumor Necrosis Factor-α Converting Enzyme Increases the Malignant Potential in Human Pancreatic Ductal Adenocarcinoma
2006 • 68 citations
THE MEMBRANE PROTEASES ADAMS AND HEPSIN ARE DIFFERENTIALLY EXPRESSED IN RENAL CELL CARCINOMA. ARE THEY POTENTIAL TUMOR MARKERS?
2004 • 50 citations
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis
2006 • 43 citations
Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer.
2007 • 37 citations
Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative α-secretases, ADAM10 and TACE, without altering their mRNA levels
2006 • 36 citations